BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11591749)

  • 1. CD4(+)CD25(+) T cells facilitate the induction of T cell anergy.
    Ermann J; Szanya V; Ford GS; Paragas V; Fathman CG; Lejon K
    J Immunol; 2001 Oct; 167(8):4271-5. PubMed ID: 11591749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.
    Zhang X; Izikson L; Liu L; Weiner HL
    J Immunol; 2001 Oct; 167(8):4245-53. PubMed ID: 11591746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+CD25high regulatory cells in human peripheral blood.
    Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
    J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells.
    Masuyama J; Kaga S; Kano S; Minota S
    J Immunol; 2002 Oct; 169(7):3710-6. PubMed ID: 12244164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
    Wells AD; Walsh MC; Bluestone JA; Turka LA
    J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression.
    Koenen HJ; Fasse E; Joosten I
    J Immunol; 2003 Dec; 171(12):6431-41. PubMed ID: 14662842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+CD25+ regulatory T cells in vivo.
    Grundström S; Cederbom L; Sundstedt A; Scheipers P; Ivars F
    J Immunol; 2003 May; 170(10):5008-17. PubMed ID: 12734345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of CD4 T cell fate by antigen re-stimulation with or without CTLA-4 engagement 24 h after priming.
    Nakata Y; Uzawa A; Suzuki G
    Int Immunol; 2000 Apr; 12(4):459-66. PubMed ID: 10744647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human gamma delta T cells are resistant to induction of anergy but not to induction of cell death in vitro.
    Pawelec G; Friccius H; Boshell M; Siegels-Hübenthal P; Rehbein A; Schlotz E; Pohla H; Schaudt K; Sansom D
    Cell Immunol; 1995 Apr; 162(1):8-15. PubMed ID: 7704914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.
    Taams LS; Smith J; Rustin MH; Salmon M; Poulter LW; Akbar AN
    Eur J Immunol; 2001 Apr; 31(4):1122-31. PubMed ID: 11298337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
    Chiffoleau E; Bériou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
    J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.
    Steinbrink K; Graulich E; Kubsch S; Knop J; Enk AH
    Blood; 2002 Apr; 99(7):2468-76. PubMed ID: 11895781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
    Kingsley CI; Karim M; Bushell AR; Wood KJ
    J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation-mediated CD4+ T cell unresponsiveness during acute Toxoplasma gondii infection in mice.
    Khan IA; Matsuura T; Kasper LH
    Int Immunol; 1996 Jun; 8(6):887-96. PubMed ID: 8671678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.
    Levings MK; Sangregorio R; Sartirana C; Moschin AL; Battaglia M; Orban PC; Roncarolo MG
    J Exp Med; 2002 Nov; 196(10):1335-46. PubMed ID: 12438424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells.
    Yamazaki S; Iyoda T; Tarbell K; Olson K; Velinzon K; Inaba K; Steinman RM
    J Exp Med; 2003 Jul; 198(2):235-47. PubMed ID: 12874257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.
    Fehérvári Z; Sakaguchi S
    Int Immunol; 2004 Dec; 16(12):1769-80. PubMed ID: 15520045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation).
    Ding L; Shevach EM
    Eur J Immunol; 1994 Apr; 24(4):859-66. PubMed ID: 7512033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.